Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1953 1
1975 1
1978 1
1979 3
1980 1
1981 1
1982 2
1983 4
1984 4
1985 5
1986 5
1987 1
1988 4
1989 3
1990 2
1991 3
1992 3
1993 8
1994 3
1995 4
1996 10
1997 9
1998 7
1999 8
2000 10
2001 9
2002 5
2003 12
2004 16
2005 12
2006 11
2007 11
2008 14
2009 16
2010 10
2011 17
2012 15
2013 17
2014 22
2015 21
2016 21
2017 14
2018 26
2019 37
2020 28
2021 31
2022 32
2023 34
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

488 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
Fornecker LM, Lazarovici J, Aurer I, Casasnovas RO, Gac AC, Bonnet C, Bouabdallah K, Feugier P, Specht L, Molina L, Touati M, Borel C, Stamatoullas A, Nicolas-Virelizier E, Pascal L, Lugtenburg P, Di Renzo N, Vander Borght T, Traverse-Glehen A, Dartigues P, Hutchings M, Versari A, Meignan M, Federico M, André M; LYSA-FIL-EORTC Intergroup. Fornecker LM, et al. Among authors: molina l. J Clin Oncol. 2023 Jan 10;41(2):327-335. doi: 10.1200/JCO.21.01281. Epub 2022 Jul 22. J Clin Oncol. 2023. PMID: 35867960 Free article. Clinical Trial.
Toward a Positive Psychology of Immigrants.
Cobb CL, Branscombe NR, Meca A, Schwartz SJ, Xie D, Zea MC, Molina LE, Martinez CR Jr. Cobb CL, et al. Among authors: molina le. Perspect Psychol Sci. 2019 Jul;14(4):619-632. doi: 10.1177/1745691619825848. Epub 2019 Apr 18. Perspect Psychol Sci. 2019. PMID: 30998855 Review.
Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells.
Bustamante-Barrientos FA, Luque-Campos N, Araya MJ, Lara-Barba E, de Solminihac J, Pradenas C, Molina L, Herrera-Luna Y, Utreras-Mendoza Y, Elizondo-Vega R, Vega-Letter AM, Luz-Crawford P. Bustamante-Barrientos FA, et al. Among authors: molina l. J Transl Med. 2023 Sep 9;21(1):613. doi: 10.1186/s12967-023-04493-w. J Transl Med. 2023. PMID: 37689642 Free PMC article. Review.
A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial.
Michallet AS, Letestu R, Le Garff-Tavernier M, Campos L, Ticchioni M, Dilhuydy MS, Morisset S, Rouille V, Mahé B, Laribi K, Villemagne B, Ferrant E, Tournilhac O, Delmer A, Molina L, Leblond V, Tomowiak C, de Guibert S, Orsini-Piocelle F, Banos A, Carassou P, Cartron G, Fornecker LM, Ysebaert L, Dartigeas C, Truchan-Graczyk M, Vilque JP, Schleinitz TA, Cymbalista F, Leprêtre S, Lévy V, Nguyen-Khac F, Feugier P. Michallet AS, et al. Among authors: molina l. Blood Adv. 2023 Aug 8;7(15):3936-3945. doi: 10.1182/bloodadvances.2022009594. Blood Adv. 2023. PMID: 37026799 Free PMC article. Clinical Trial.
Solvent tolerance in Gram-negative bacteria.
Segura A, Molina L, Fillet S, Krell T, Bernal P, Muñoz-Rojas J, Ramos JL. Segura A, et al. Among authors: molina l. Curr Opin Biotechnol. 2012 Jun;23(3):415-21. doi: 10.1016/j.copbio.2011.11.015. Epub 2011 Dec 10. Curr Opin Biotechnol. 2012. PMID: 22155018 Review.
Alopecia areata incognita.
Molina L, Donati A, Valente NS, Romiti R. Molina L, et al. Clinics (Sao Paulo). 2011;66(3):513-5. doi: 10.1590/s1807-59322011000300027. Clinics (Sao Paulo). 2011. PMID: 21552683 Free PMC article. No abstract available.
488 results